Latest news

NEW ANALYSIS OF MEDICAID SPENDING REINFORCES VALUE AND PATIENT IMPACT OF FDA ACCELERATED APPROVAL PATHWAY
Data support preserving access to accelerated approval drugs for the seriously ill   Commentary in the American Journal of Managed Care warns that restricting access to accelerated approval therapies has minimal budget implications, but poses significant harm to patients   March 30,
Press release
Mar 30,2021
Biden administration needs a national pandemic preparedness strategy
Defeating this scourge will be the President-elect's greatest challenge By Kenneth E. Thorpe - - Wednesday, December 16, 2020   ANALYSIS/OPINION:   COVID-19 has killed more than 300,000 Americans. And with case counts and hospitalizations soaring, many
OP-ED
Dec 17,2020
The pandemic is making Americans afraid of going to the doctor for any reason at all
Sacrificing regular doctor visits in order to socially distance is not a good idea. Here’s why By KENNETH E. THORPE DECEMBER 6, 2020 7:00PM (UTC) Millions of Americans have postponed lifesaving screenings and other preventative care due to COVID-19, according to an
OP-ED
Dec 8,2020
After taming the COVID outbreak, focus on antibiotics to fight superbugs
By KENNETH E. THORPE ORLANDO SENTINEL  DEC 07, 2020 AT 5:30 AM     The end of the COVID-19 pandemic is finally in sight.   Pfizer recently announced that its
OP-ED
Dec 8,2020
TRUMP ADMINISTRATION'S DRUG REBATE REFORM OFFERS RELIEF FOR CHRONICALLY ILL
WASHINGTON, D.C. (November 20, 2020) The Partnership to Fight Chronic Disease has issued the following statement in response to the Trump Administration’s Final Rule to extend benefits of drug rebates to Medicare beneficiaries:   “Rebates lower drug costs for insurers, but
Press release
Nov 20,2020
PARTNERSHIP TO FIGHT CHRONIC DISEASE DENOUNCES ADMINISTRATION’S MOST FAVORED NATION MODEL
Proposed "Most Favored Nation" Medicare model will hinder biomedical research and harm Medicare beneficiaries living with chronic diseases   WASHINGTON, D.C. (November 20, 2020) The Partnership to Fight Chronic Disease has issued the following statement in response to the Trump
Press release
Nov 20,2020
New Medicaid proposal will put treatments and cures even further out of reach
By Kenneth E. Thorpe President Trump has long promised to lower prescription drug prices. Unfortunately, two of his administration’s newest proposals would actually raise out-of-pocket costs and reduce access to medicines.   They must be scrapped before they do real
OP-ED
Nov 11,2020
President Trump's Recent Healthcare Executive Order Does Little to Protect Patients or Lower Healthcare Costs
WASHINGTON, D.C. (September 28, 2020) -- Kenneth Thorpe, chairman of the Partnership to Fight Chronic Disease, issued the following statement in response to President Donald Trump's America-First Healthcare Plan executive order:   "President Trump's latest executive order claims
Press release
Oct 5,2020
President Trump's Drug Pricing Executive Order Undercuts the Fight Against Chronic Disease
The "Most Favored Nations" Executive Order will harm patients by hindering biomedical research   WASHINGTON, D.C. (September 14, 2020) -- Kenneth Thorpe, chairman of the Partnership to Fight Chronic Disease, issued the following statement in response to
Press release
Sep 15,2020
PARTNERSHIP TO FIGHT CHRONIC DISEASE CONDEMNS PRESIDENT TRUMP'S EXECUTIVE ORDER ON DRUG PRICING
"Favored Nations Rule" will reduce access to medicines and stifle biomedical research   WASHINGTON, D.C. (July 24, 2020) – Kenneth Thorpe, Chairman of the Partnership to Fight Chronic Disease, has issued the following statement in response to President Donald Trump's
Press release
Jul 25,2020

Pages